← brief for 2026-10-14 · Slowing decline

Efsubaglutide Alfa: A Comprehensive Pharmacological Review.

Paper No results yet Peer reviewed

Key takeaways

This is a review of a new long-acting drug for diabetes and weight. It explains how the drug works in the body. It looks at how long it stays in the system and how it might interact with other drugs. It does not report new test results from a single trial.

Who did this work

Zheng H · Yan R · Jiang F · Li Y · Prud'homme GJ · Wang Q

Source

Paper · PubMed, the drug frontier · 2026 Oct 13
https://pubmed.ncbi.nlm.nih.gov/42870102/